A total of 10 individuals with HIV have been cured to date. Most of these patients have remained anonymous, but three have ...

The discovery of broadly neutralizing antibodies (bNAbs) like b12 in 1994 marked a turning point in HIV research. B12 ...

Lenacapavir has delivered impressive trial results and, in July, it received official backing from the World Health ...

The WHO approves lenacapavir every six months as a new step in HIV prevention, simplifying diagnoses and expanding ...

A recent study by the German Center for Infection Research reveals how HIV integrates its genetic material into human DNA, potentially leading to new treatment strategies.

Lenacapavir is a long-acting injectable antiretroviral drug developed by Gilead Sciences. It is administered just twice a year and has demonstrated over 99.9% effectiveness in preventing HIV ...

Wes Sundquist wasn't trying to become one of TIME's 100 most influential people in the world. He wasn't shooting for Science ...

Lenacapavir has the potential to end the HIV epidemic, researchers say. The Trump administration says backing this kind of ...

Deputy Minister of Health, Dr Joe Phaahla, has hailed long-acting injectables such as Lenacapavir as a game-changer poised to revolutionise HIV prevention, especially for adolescent girls, young women ...

The twice-yearly drug has been hailed as a medical breakthrough that could change the course of the HIV epidemic.

Advances in HIV medication, its window of detection and its transmission risk within the last decade have led to an updated ...

New partnership will join others to expand access to generic lenacapavir for millions more people at risk of HIV in high-burden countries—bringing the world closer to ending the epidemic - Kenya ...